Discover and read the best of Twitter Threads about #Cannabinoid

Most recents (3)

A summary thread from the great Emergency Medicine Australasia issue I finally read on the plane; @EMAJournal #foamed

Thom study in EMA: patients with unstable cervical #fractures can sit (29%), walk (63%), lack midline tenderness (27%), and have delayed presentation (20%).
@EMAJournal #emergencymedicine

surf injuries were mostly lower c-spine

NEXUS underperformed compared to Canadian C-spine.

#drowning and cervical CTs are not inextricably linked: don't automatically image unless signs of axial loading/very specific concerns
@EMAJournal [my $0.02 on immobilising (virtually) anyone prehospitally: cervical immobilisation is a myth: collars don't actually immobilise, and 'immobilisation' doesn't actually prevent neurological injury...it *does* however harm (eg aspiration and other harms)]
Read 31 tweets
Ich möchte darauf hinweisen, weil es ein Zeitlang ganz gut bekannt war und etwas in Vergessenheit geraten zu sein scheint:
Wir Menschen haben an vielen stellen im Körper, in Organen und im Nervensystem, in der Muskulatur und in den Knochen, Aufnahmestellen für Cannabinoide.
Die #Cannabinoide dazu haben wir auch im Körper.
Dann gibt es eine Pflanzengattung, die hat auch Cannabinoide. Diese passen ganz gut an die Rezeptoren für körpereigene, ähnliche Stoffe.
Und jetzt erkläre mir doch bitte nochmal, wieso die Pflanze und die Anwendung verboten bleibt
Ich hätte dann bitte auch gerne erklärt, warum das körpereigene (endogene) #Cannabinoid System bis heute nicht fester Bestandteil der medizinischen Ausbildung ist, und wieso wir nur über die Gefahren reden, und niemals über den Nutzen.
Read 3 tweets
ATTN #CBD stakeholders: @US_FDA today holding scientific conf. on CBD/other #cannabinoids. I'll be live tweeting throughout. Not sure we'll get much insight on immediate path forward for consumer products but I'll share noteworthy observations. Agenda: bit.ly/3pHXU8V
I'll be paying particular attention to @DrAbernethyFDA's remarks at 9:05a (head of #FDA's #CBD Policy Working Group) and @DThrockmortonMD's keynote at 9:15a (one of Agency's principals for regulating R&D, manufacture & marketing of #cannabis & cannabis-derived #drug products).
And we're underway! First up is Kaveeta Vasisht, MD, PharmD. Associate Commissioner for Women’s
Health and Director, Office of Women’s Health, FDA. She's noting ubiquity of #CBD products in marketplace, many of which are targeted to #women.
Read 56 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!